{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:08:13Z","timestamp":1773115693655,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/201.037\/2020"],"award-info":[{"award-number":["E-26\/201.037\/2020"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11033-021-06524-5","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:03:20Z","timestamp":1625130200000},"page":"5199-5207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species"],"prefix":"10.1007","volume":"48","author":[{"given":"J\u00e9ssica Sodr\u00e9 Silva","family":"de Abreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-6101","authenticated-orcid":false,"given":"Jana\u00edna","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"6524_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00709-4","volume":"7","author":"J Choi","year":"2017","unstructured":"Choi J, Park J, Cho H et al (2017) Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor. Sci Rep 7:1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-00709-4","journal-title":"Sci Rep"},{"key":"6524_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2174\/157340609788681485","volume":"5","author":"A Sturzu","year":"2012","unstructured":"Sturzu A, Vogel U, Gharabaghi A et al (2012) Cell nucleus directed 2,3,5-triiodobenzoic acid conjugates. Med Chem 5:385\u2013391. https:\/\/doi.org\/10.2174\/157340609788681485","journal-title":"Med Chem"},{"key":"6524_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biomaterials.2016.01.060","volume":"85","author":"JY Lee","year":"2016","unstructured":"Lee JY, Chung SJ, Cho HJ et al (2016) Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging. Biomaterial 85:218\u2013231. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.01.060","journal-title":"Biomaterial"},{"key":"6524_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.mric.2017.06.003","volume":"25","author":"MV Spampinato","year":"2017","unstructured":"Spampinato MV, Abid A, Matheus MG (2017) Current radiographic iodinated contrast agents. Magn Reson Imaging Clin N Am 25:697\u2013704. https:\/\/doi.org\/10.1016\/j.mric.2017.06.003","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"6524_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.mric.2017.06.008","volume":"25","author":"B Boyd","year":"2017","unstructured":"Boyd B, Zamora CA, Castillo M (2017) Managing adverse reactions to contrast agents. Magn Reson Imaging Clin N Am 25:737\u2013742. https:\/\/doi.org\/10.1016\/j.mric.2017.06.008","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"6524_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/heartjnl-2014-306962","volume":"102","author":"R Rear","year":"2016","unstructured":"Rear R, Bell RM, Hausenloy DJ (2016) Contrast-induced nephropathy following angiography and cardiac interventions. Heart 102:638\u2013648. https:\/\/doi.org\/10.1136\/heartjnl-2014-306962","journal-title":"Heart"},{"key":"6524_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jon.12356","volume":"26","author":"E Rowe","year":"2016","unstructured":"Rowe E, Rowe V, Biswas S, Mosher G et al (2016) Preclinical studies of a kidney safe iodinated contrast agent. J Neuroimaging 26:511\u2013518. https:\/\/doi.org\/10.1111\/jon.12356","journal-title":"J Neuroimaging"},{"key":"6524_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DHPS.S122207","volume":"9","author":"M Andreucci","year":"2017","unstructured":"Andreucci M, Faga T, Serra R et al (2017) Update on the renal toxicity of iodinated contrast drugs used in clinical medicine. Drug Healthc Patient Saf 9:25\u201337. https:\/\/doi.org\/10.2147\/DHPS.S122207","journal-title":"Drug Healthc Patient Saf"},{"key":"6524_CR9","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9243","author":"X Wang","year":"2020","unstructured":"Wang X, Zhou J, Wang J et al (2020) Role of TLR4\/MyD88\/NF-κB signaling in the contrast-induced injury of renal tubular epithelial cells. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2020.9243","journal-title":"Exp Ther Med"},{"key":"6524_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/bmdcn\/2018080101","volume":"8","author":"J Yang","year":"2018","unstructured":"Yang J, Peng Y, Tsai S et al (2018) The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM). BioMedicine 8:1\u201311. https:\/\/doi.org\/10.1051\/bmdcn\/2018080101","journal-title":"BioMedicine"},{"key":"6524_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG (2018) ROS signalling in the biology of cancer. Semin Cell Dev Biol 80:50\u201364. https:\/\/doi.org\/10.1016\/j.semcdb.2017.05.023","journal-title":"Semin Cell Dev Biol"},{"key":"6524_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110735","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal V, Tuli H, Varol A et al (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. https:\/\/doi.org\/10.3390\/biom9110735","journal-title":"Biomolecules"},{"key":"6524_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani R, Wang H et al (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37:1\u201310. https:\/\/doi.org\/10.1186\/s13046-018-0909-x","journal-title":"J Exp Clin Cancer Res"},{"key":"6524_CR14","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1021\/acs.jmedchem.6b01243","volume":"60","author":"AT Dharmaraja","year":"2017","unstructured":"Dharmaraja AT (2017) Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria. J Med Chem 60:3221\u20133240. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01243","journal-title":"J Med Chem"},{"key":"6524_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"A Carpenter","year":"2006","unstructured":"Carpenter A, Jones T, Lamprecht M et al (2006) Cell profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7:10. https:\/\/doi.org\/10.1186\/gb-2006-7-10-r100","journal-title":"Genome Biol"},{"key":"6524_CR16","first-page":"143","volume":"22","author":"F Ferr\u00e3o","year":"2018","unstructured":"Ferr\u00e3o F, Lima A, Abreu J et al (2018) 2,3,5-Triiodobenzoic acid (TIBA), a diagnostic contrast, induces caspase dependent cell death through intrinsic pathway in NSCLC. Curr Topics Pharmacol 22:143\u2013149","journal-title":"Curr Topics Pharmacol"},{"key":"6524_CR17","first-page":"1879","volume":"41","author":"S Zilkah","year":"1981","unstructured":"Zilkah S, Osband M, McCaffrey R (1981) Effect of inhibitors of plant cell division on mammalian tumor cells in vitro. Cancer Res 41:1879\u20131883","journal-title":"Cancer Res"},{"key":"6524_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1590\/s0102-865020180060000005","volume":"33","author":"O Ozturk","year":"2018","unstructured":"Ozturk O, Eroglu H, Ustebay S et al (2018) An experimental study on the preventive effects of N-acetyl-cysteine and ozone treatment against contrast-induced nephropathy. Acta Cir Bras 33:508\u2013517. https:\/\/doi.org\/10.1590\/s0102-865020180060000005","journal-title":"Acta Cir Bras"},{"key":"6524_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0226696","volume":"14","author":"A Alnahdi","year":"2019","unstructured":"Alnahdi A, John A, Raza H (2019) N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose\/high palmitic acid treatment in pancreatic Rin-5F cells. PLoS ONE 14:1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0226696","journal-title":"PLoS ONE"},{"key":"6524_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/jcp.25118","volume":"3","author":"R Ciarcia","year":"2016","unstructured":"Ciarcia R, Damiano S, Puzio M (2016) Comparison of dasatinib, nilotinib, and imatinib in the treatment of chronic myeloid leukemia. J Cell Phisiol 3:680\u2013687. https:\/\/doi.org\/10.1002\/jcp.25118","journal-title":"J Cell Phisiol"},{"key":"6524_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7508\/ibj.2016.01.009","volume":"20","author":"A Bazi","year":"2016","unstructured":"Bazi A, Keramati M, Gholamin M (2016) Role of oxidative stress in modulating unfolded protein response activity in chronic myeloid leukemia cell line. Iran Biomed J 20:63\u201367. https:\/\/doi.org\/10.7508\/ibj.2016.01.009","journal-title":"Iran Biomed J"},{"key":"6524_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","volume":"1","author":"C Reczek","year":"2017","unstructured":"Reczek C, Chandel N (2017) The two faces of reactive oxygen species in cancer. Annu Rev Cancer Biol 1:79\u201398. https:\/\/doi.org\/10.1146\/annurev-cancerbio-041916-065808","journal-title":"Annu Rev Cancer Biol"},{"key":"6524_CR23","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"U Srinivas","year":"2019","unstructured":"Srinivas U, Tan B, Vellayappan B et al (2019) ROS and the DNA damage response in cancer. Redox Biol 25:2213\u20132317. https:\/\/doi.org\/10.1016\/j.redox.2018.101084","journal-title":"Redox Biol"},{"key":"6524_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/ars.2016.6665","volume":"3","author":"B Ratliff","year":"2016","unstructured":"Ratliff B, Abdulmahdi W, Pawar R et al (2016) Oxidant mechanisms in renal injury and disease. Antioxid Redox Signal 3:119\u2013146. https:\/\/doi.org\/10.1089\/ars.2016.6665","journal-title":"Antioxid Redox Signal"},{"key":"6524_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00775-019-01661-6","volume":"24","author":"J Fernandes","year":"2019","unstructured":"Fernandes J, Amorim G, Veiga T et al (2019) Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management. J Biol Inorg Chem 24:547\u2013562. https:\/\/doi.org\/10.1007\/s00775-019-01661-6","journal-title":"J Biol Inorg Chem"},{"key":"6524_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/jrr\/rru085","volume":"2","author":"N Kubo","year":"2015","unstructured":"Kubo N, Noda S, Takahashi A (2015) Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460. J Radiat Res 2:229\u2013238. https:\/\/doi.org\/10.1093\/jrr\/rru085","journal-title":"J Radiat Res"},{"key":"6524_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.17480\/psk.2020.64.2.156","volume":"2","author":"S Kim","year":"2020","unstructured":"Kim S, Yang YM, Choi E (2020) Comparative study of carboplatin dosing in lung cancer patients using the Calvert formula and four equations for estimating glomerular filtration rate. Pharm Soc Korea 2:156\u2013165. https:\/\/doi.org\/10.17480\/psk.2020.64.2.156","journal-title":"Pharm Soc Korea"},{"key":"6524_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11547-020-01253-4","volume":"126","author":"C Saade","year":"2021","unstructured":"Saade C, Karout L, Khalil A et al (2021) Impact of various iodine concentrations of iohexol and iodixanol contrast media on image reconstruction techniques in a vascular-specific contrast media phantom: quantitative and qualitative image quality assessment. Card Radiol 126:221\u2013230. https:\/\/doi.org\/10.1007\/s11547-020-01253-4","journal-title":"Card Radiol"},{"key":"6524_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wnan.1642","volume":"12","author":"J Hsu","year":"2020","unstructured":"Hsu J, Nieves L, Betzer O et al (2020) Nanoparticle contrast agents for X-ray imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12:1\u201326. https:\/\/doi.org\/10.1002\/wnan.1642","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"6524_CR30","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1039\/C8CS00921J","volume":"48","author":"X Chen","year":"2019","unstructured":"Chen X, Song J, Chen X, Yang H (2019) X-ray-activated nanosystems for theranostic applications. Chem Soc Rev 48:3073\u20133101. https:\/\/doi.org\/10.1039\/C8CS00921J","journal-title":"Chem Soc Rev"},{"key":"6524_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11095-015-1813-0","volume":"33","author":"M Attia","year":"2016","unstructured":"Attia M, Anton N, Aksov R et al (2016) Biodistribution and toxicity of X-Ray iodinated contrast agent in nano-emulsions in function of their size. Pharm Res 33:603\u2013614. https:\/\/doi.org\/10.1007\/s11095-015-1813-0","journal-title":"Pharm Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06524-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:12:02Z","timestamp":1627477922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06524-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6524"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06524-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}